Sign in
Taking people in United StatesPhase 2

Studying Estradiol Effects on Hormones in Women With Obesity and Infertility

Tests estradiol patches in women with obesity and fertility problems, aged 18 to 38.

Key facts

Who runs it
University of Colorado, Denver
Where
Aurora, United StatesSee the site
Trial code
Registry title
Convergent Mechanisms Underlying Reprometabolic Syndrome in Women
Status
Recruiting
Phase
Phase 2
People taking part
20 people, planned
Started
25 Feb 2025
Expected to end
Dec 2027
Type of study
Interventional, 2 groups
Treatments tested
  • Estradiol Patches
Record updated
21 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for women aged 18-38 with regular menstrual cycles. It studies how obesity changes the body's response to estradiol and the hormones in the brain that control the cycle.

Age
18 to 38 years
Sex
Women only
Earlier treatment
No reproductive hormones in the past 3 months. No medicines that interact with reproductive hormones.
Biomarker or test result
Normal thyroid stimulating hormone, prolactin and lipid profiles.

Main reasons for not taking part

  • Has diabetes
  • Is a smoker
  • History of venous thromboembolism or known thrombophilia
  • History of estrogen dependent cancer
  • Positive pregnancy test

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Age 18-38
  • Regular menstrual cycles every 25-35 days
  • No use of reproductive hormones within the past 3 months
  • No use of medications interacting with reproductive hormones
  • Agreement to use reliable barrier contraception or to abstain from intercourse for the duration of the study
  • Normal thyroid stimulating hormone, prolactin and lipid profiles
  • No more than 4 hours of moderate to vigorous intensity exercise per week
  • No history of chronic disease impacting reproductive hormones
  • No contraindications to administration of estradiol
  • No history of estrogen dependent cancer
  • Negative pregnancy test

Who cannot take part

  • Has diabetes
  • History of venous thromboembolism or known thrombophilia
  • Is a smoker

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 38 years old?

Where in United States

  • University of Colorado School of MedicineAurora, United StatesContact: Carrie HsuTaking people

About the trial

What the trial wants to find out

Dr. Nanette Santoro proposes to test the specific question that obesity results in abnormal estradiol response at the level of the pituitary and hypothalamus. This will be shown in diminished pituitary sensitivity to gonadorelin releasing hormone with a reduced estradiol induced luteinizing hormone surge in obese women.

The 2 groups in the trial

  • Estradiol Patch- Normal Weight womenTreatment being tested

    Normal weight women (NWW) will wear a Transdermal estradiol patch for 7 days and collect urine to determine LH surge.

    Treatment: Estradiol Patches

  • Estradiol Patch- Women with high BMITreatment being tested

    Women with a BMI greater than 30 kg/m2 will wear a Transdermal estradiol patch for 7 days and collect urine to determine LH surge.

    Treatment: Estradiol Patches

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Convergent Mechanisms Underlying Reprometabolic Syndrome in Women and Sheep
Plain-language title
Studying Estradiol Effects on Hormones in Women With Obesity and InfertilityGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06686537, who can take part
Record updated
21 July 2026